A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial-Reference-Cited by-同舟云学术

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Published:2005-05 Issue:5 Volume:80 Page:587-595
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Pearson Thomas A.,Denke Margo A.,McBride Patrick E.,Battisti Wendy P.,Brady William E.,Palmisano Joanne

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;JAMA,2001

2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [published correction appears in Circulation. 2004;110:763];Grundy;Circulation,2004

3. Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events;Foley;Am J Cardiol,2003

4. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals;Pearson;Arch Intern Med,2000

5. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000;Ford;Circulation,2003

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future;Current Problems in Cardiology;2024-07

2. Is there a role for earlier use of combination therapy?;American Journal of Preventive Cardiology;2024-03

3. Dyslipidemia: A Narrative Review on Pharmacotherapy;Pharmaceuticals;2024-02-23

4. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review;Journal of Clinical Medicine;2024-02-07

5. Ezetimibe increases resistance to oxidative stress and extends lifespan mimicking dietary restriction in Caenorhabditis elegans;Bioscience Journal;2023-02-24